Eton Pharmaceuticals (ETON) Total Current Liabilities (2017 - 2026)

Eton Pharmaceuticals has reported Total Current Liabilities for 9 years, with the latest figure at $38.5 million in Q4 2025.

• Quarterly Total Current Liabilities rose 92.96% year-over-year to $38.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $38.5 million (up 92.96% YoY) and the FY2025 annual result came in at $38.5 million, up 92.96% from the prior year.
• Total Current Liabilities retreated to $38.5 million in Q4 2025 per ETON's latest filing, from $44.2 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $44.2 million in Q3 2025 and troughed at $3.1 million in Q2 2021.
• A 5-year average of $14.9 million and a median of $10.0 million in 2023 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2022 and 2023: Total Current Liabilities slipped 13.04% in 2022, then surged 151.52% in 2023.
• Over 5 years, Total Current Liabilities stood at $4.6 million in 2021, then surged by 41.75% to $6.5 million in 2022, then soared by 151.37% to $16.2 million in 2023, then gained by 22.82% to $19.9 million in 2024, then soared by 92.96% to $38.5 million in 2025.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $38.5 million, $44.2 million, and $38.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.